Johnson & Johnson (JNJ) Competitors $169.62 +0.52 (+0.31%) Closing price 07/24/2025 03:59 PM EasternExtended Trading$169.36 -0.26 (-0.15%) As of 06:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock JNJ vs. ISRG, MRNA, NVAX, ABBV, BRK.B, LLY, MRK, PFE, PG, and XOMShould you be buying Johnson & Johnson stock or one of its competitors? The main competitors of Johnson & Johnson include Intuitive Surgical (ISRG), Moderna (MRNA), Novavax (NVAX), AbbVie (ABBV), Berkshire Hathaway (BRK.B), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK), Pfizer (PFE), Procter & Gamble (PG), and Exxon Mobil (XOM). Johnson & Johnson vs. Its Competitors Intuitive Surgical Moderna Novavax AbbVie Berkshire Hathaway Eli Lilly and Company Merck & Co., Inc. Pfizer Procter & Gamble Exxon Mobil Intuitive Surgical (NASDAQ:ISRG) and Johnson & Johnson (NYSE:JNJ) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Is ISRG or JNJ more profitable? Intuitive Surgical has a net margin of 28.51% compared to Johnson & Johnson's net margin of 25.00%. Johnson & Johnson's return on equity of 33.07% beat Intuitive Surgical's return on equity.Company Net Margins Return on Equity Return on Assets Intuitive Surgical28.51% 14.56% 12.93% Johnson & Johnson 25.00%33.07%13.16% Does the media refer more to ISRG or JNJ? In the previous week, Johnson & Johnson had 36 more articles in the media than Intuitive Surgical. MarketBeat recorded 128 mentions for Johnson & Johnson and 92 mentions for Intuitive Surgical. Johnson & Johnson's average media sentiment score of 1.28 beat Intuitive Surgical's score of 1.17 indicating that Johnson & Johnson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intuitive Surgical 58 Very Positive mention(s) 8 Positive mention(s) 14 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Johnson & Johnson 103 Very Positive mention(s) 5 Positive mention(s) 9 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer ISRG or JNJ? Intuitive Surgical currently has a consensus target price of $592.05, indicating a potential upside of 21.17%. Johnson & Johnson has a consensus target price of $174.50, indicating a potential upside of 2.88%. Given Intuitive Surgical's higher possible upside, equities research analysts plainly believe Intuitive Surgical is more favorable than Johnson & Johnson.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intuitive Surgical 1 Sell rating(s) 5 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.65Johnson & Johnson 0 Sell rating(s) 9 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 2.65 Which has higher earnings & valuation, ISRG or JNJ? Johnson & Johnson has higher revenue and earnings than Intuitive Surgical. Johnson & Johnson is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntuitive Surgical$8.35B20.97$2.32B$6.8271.64Johnson & Johnson$88.82B4.59$14.07B$9.3518.14 Do insiders and institutionals believe in ISRG or JNJ? 83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 69.6% of Johnson & Johnson shares are held by institutional investors. 0.7% of Intuitive Surgical shares are held by insiders. Comparatively, 0.2% of Johnson & Johnson shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, ISRG or JNJ? Intuitive Surgical has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500. Comparatively, Johnson & Johnson has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. SummaryIntuitive Surgical and Johnson & Johnson tied by winning 8 of the 16 factors compared between the two stocks. Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JNJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JNJ vs. The Competition Export to ExcelMetricJohnson & JohnsonLarge Cap Pharma IndustryMedical SectorNYSE ExchangeMarket Cap$406.87B$257.96B$5.73B$21.15BDividend Yield3.08%2.82%4.60%3.58%P/E Ratio18.1427.9327.9827.76Price / Sales4.595.09447.4658.49Price / Cash12.8914.1136.5523.00Price / Book5.7117.978.654.67Net Income$14.07B$8.49B$3.24B$993.85M7 Day Performance3.65%3.75%3.69%1.48%1 Month Performance11.35%3.75%10.34%5.79%1 Year Performance6.21%-5.54%34.36%11.41% Johnson & Johnson Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JNJJohnson & Johnson4.8288 of 5 stars$169.62+0.3%$174.50+2.9%+8.5%$406.87B$88.82B18.14138,100Trending NewsAnalyst UpgradeISRGIntuitive Surgical4.6974 of 5 stars$518.31-0.1%$592.86+14.4%+7.6%$185.67B$8.35B75.9615,638Trending NewsEarnings ReportAnalyst ForecastMRNAModerna4.2558 of 5 stars$31.55+0.9%$46.61+47.8%-71.2%$12.17B$3.24B-3.605,800Upcoming EarningsAnalyst ForecastNVAXNovavax4.3034 of 5 stars$7.01+0.1%$17.00+142.7%-50.4%$1.13B$682.16M2.641,990News CoverageAnalyst ForecastOptions VolumeGap UpABBVAbbVie4.8831 of 5 stars$186.10-1.7%$211.29+13.5%+8.3%$328.66B$56.33B79.1855,000Trending NewsUpcoming EarningsBRK.BBerkshire Hathaway0.6514 of 5 stars$477.14+0.7%$520.00+9.0%+11.3%$1.03T$371.43B12.72392,400LLYEli Lilly and Company4.9796 of 5 stars$764.66-0.9%$1,012.56+32.4%-6.4%$724.88B$49.00B62.2347,000Trending NewsMRKMerck & Co., Inc.4.9962 of 5 stars$79.48-0.6%$108.69+36.8%-33.1%$199.62B$64.17B11.5775,000Positive NewsUpcoming EarningsDividend AnnouncementPFEPfizer4.9781 of 5 stars$24.470.0%$28.55+16.7%-15.4%$139.15B$63.63B17.7481,000Trending NewsOptions VolumePGProcter & Gamble4.8084 of 5 stars$155.71+0.4%$176.84+13.6%-5.5%$364.97B$83.93B24.71108,000Positive NewsUpcoming EarningsXOMExxon Mobil4.9396 of 5 stars$108.37+0.6%$125.42+15.7%-3.6%$467.22B$349.59B14.3861,000Trending NewsUpcoming EarningsAnalyst Revision Related Companies and Tools Related Companies Intuitive Surgical Competitors Moderna Competitors Novavax Competitors AbbVie Competitors Berkshire Hathaway Competitors Eli Lilly and Company Competitors Merck & Co., Inc. Competitors Pfizer Competitors Procter & Gamble Competitors Exxon Mobil Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:JNJ) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Share Johnson & Johnson With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.